Micron Technology, Inc. (NASDAQ:MU) shares tumbled 3.89%, at $65.56, in premarket after it posted fiscal fourth-quarter revenue that came in short of expectations.
The chipmaker posted an adjusted loss of $1.07 per share on revenue of $4.01 billion, versus $1.45 on $6.44 billion a year ago. Analysts expected to see a slightly bigger $1.11 per share on less revenue.
Unfortunately for investors, however, the company also said it expects the current quarter to show a wider loss in a range between $1 and $1.14.
GameStop Corp (NYSE:GME) rallied nearly 8.6% after the video game retailer, meme-stock and true-life inspiration for the ‘Dumb Money’ movie announced the appointment of chair Ryan Cohen will also become president and chief executive.
Peloton Interactive Inc (NASDAQ:PTON) and Lululemon Athletica (NASDAQ:LULU) both advanced in early deals, up 13.5% and 0.6%, after the adjacent fitness brands agreed a digital content and apparel collab.
Small-cap drug developer Bionomics Ltd (ASX:BNO, OTCQB:BNOEF) saw gains in excess of 300% in Thursday’s early deals, trading up to $4.25, after positive results from a PTSD drug trial.
It wasn’t going as well for BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI) as its stock more than halved in value after the FDA advisory committee voted against its cell therapy for Lou Gehrig's disease, with the regulator’s advisors saying the candidate didn’t substantial evidence of effectiveness.
Workday Inc (NASDAQ:WDAY) stock plunged 10% lower after the HR software maker, at an investor presentation, reduced its forecasts regarding annual subscription revenue growth, to 17-19% from +20%.